Bradley Magill, DPM
Podiatrist · du Bois, PANPI 1710991500
Payments from drug & device makers
Across 224 payments — averaging $15.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$1K
- Organogenesis Inc.$786
- AbbVie$402
- Misonix Inc$128
- Celularity Inc.$119
- Tactile Systems Technology Inc$103
- plus $786 from 25 others
What the payments were for
- Speaking & faculty fees$612%
- Food & beverage$3,45598%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 100 | $1,205 |
| Organogenesis Inc. | 37 | $786 |
| AbbVie(2 entities) | 25 | $402 |
| Misonix Inc | 6 | $128 |
| Celularity Inc. | 9 | $119 |
| Tactile Systems Technology Inc | 4 | $103 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $82 |
| Nestle Healthcare Nutrition Inc. | 5 | $81 |
| Stryker | 2 | $69 |
| Paratek Pharmaceuticals, Inc. | 4 | $64 |
| Osiris Therapeutics Inc. | 3 | $54 |
| Mimedx Group, Inc. | 2 | $44 |
| Integra Lifesciences Corporation | 2 | $38 |
| Bioventus LLC | 2 | $35 |
| Reprise Biomedical, Inc. | 2 | $34 |
| Urgo Medical North America, LLC | 1 | $33 |
| Pharming Healthcare, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Abbott | 1 | $20 |
| Novo Nordisk | 1 | $20 |
| Octapharma USA, Inc. | 1 | $17 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $15 |
| Polynovo North America LLC | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Amgen | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $13 |
| Melinta Therapeutics, LLC | 1 | $12 |
How this compares
$3,529 in reported general payments places this provider in the 80th percentile of 445 podiatrist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine Hcl | 59 | $6,816 |
| Celecoxib | 17 | $366 |
| Levofloxacin | 38 | $287 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $237 |
| Ammonium Lactate | 11 | $222 |
| Doxycycline Hyclate | 34 | $197 |
| Gabapentin | 16 | $142 |
| Terbinafine Hcl | 12 | $92 |
| Pregabalin | 13 | $86 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in du Bois
- Kaitlyn Krugdu Bois$7K
- Mark HofbauerBelle Vernon$1.1M
- Daniel PerezPhiladelphia$434K
- Christopher BarrettChester$229K
- Alan CatanzaritiPittsburgh$80K
- John StarinskiPen Argyl$74K
- Kwasi KwaaduPhiladelphia$65K
- Luke CicchinelliPhiladelphia$62K
- James McGuirePhiladelphia$60K
- John SchelandClarks Summit$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.